Paul Thomas Reynolds, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2400 Mount Zion Pkwy, Jonesboro, GA 30236 Phone: 615-337-6920 |
Rodney L Harris, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2470 Mount Zion Pkwy, Department Of Gastroenterolgy, Jonesboro, GA 30236 Phone: 770-603-3811 Fax: 770-603-3776 |
Kabir A Quadir, PAC Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: Department Of Gastroenterology, 2470 Mount Zion Parkway, Jonesboro, GA 30236 Phone: 770-603-3810 |
Celestine O Maiki, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7823 Spivey Station Blvd Ste 100, Jonesboro, GA 30236 Phone: 404-251-2680 Fax: 404-252-2688 |
Kenny M Frontin, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2470 Mount Zion Pkwy, Department Of Gastroenterology, Jonesboro, GA 30236 Phone: 770-603-3822 |
Rahul S Nayak, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2470 Mount Zion Pkwy, Kaiser Permanente - Southwood Specialty Office, Jonesboro, GA 30236 Phone: 770-603-3759 |
News Archive
News outlets analyzed the current political climate as the Senate Finance Committee prepares for a Tuesday vote on health overhaul legislation.
Amgen Inc. today announced the publication of results from the first open-label study to compare Nplate® (romiplostim) treatment to standard of care therapies (SOC) in non-splenectomized adult patients with chronic immune thrombocytopenia (ITP). The study results, which were published today in the New England Journal of Medicine (NEJM), show that both the incidence of treatment failure and need for splenectomy were reduced among the Nplate-treated patients.
In the hunt for novel treatments against an aggressive form of breast cancer, researchers combined a new protein inhibitor with a chemotherapy drug to create a powerful combination that resulted in cancer cell death.
Pregnant women may be especially vulnerable to developing more severe cases of COVID-19 following SARS-CoV-2 infection, but little is known about their anti-SARS-CoV-2 immune response or how it may affect their offspring.
Now, a new study published on the preprint server medRxiv* by scientists at the University of New South Wales aimed to determine the public perfections regarding a future COVID-19 vaccine in Australia. They wanted to know if Australians would get the vaccine if one becomes available.
› Verified 7 days ago